PubMed Health⌕ Search

Biomedical subjects

Brian R James

Publications and source records attributed to Brian R James.

13 recordsLinked to original sources

Alpha-monodeuterated benzyl alcohols and phosphobetaines from reactions of aromatic aldehydes with a water/D2O-soluble phosphine.

With the aim of learning more about the bleaching action of pulps by (hydroxymethyl)phosphines, we reacted several benzaldehydes, containing MeO, Me, OH, or halogen substituents, with tris(3-hydroxypropyl)phosphine, [HO(CH2)3]3P, in aqueous solution at 90 degrees C under argon. Effective reduction of the aldehydes to the corresponding benzyl alcohols with concomitant oxidation of the phosphine to the phosphine oxide takes place, the reaction proceeding via an initially formed phosphonium species. When the reactions are carried out in D2O, the benzyl alcohol product from 3,4-dimethoxybenzaldehyde contains one deuterium atom at the benzyl-carbon atom, consistent with the last step of the mechanism involving a carbanion intermediate. With syringaldehyde (3,5-dimethoxy-4-hydroxy-benzaldehyde), the reduction product (syringyl alcohol) is more reactive toward the phosphine than is the starting aldehyde, and a zwitterionic, phosphobetaine product is formed. In D2O, the zwitterion benzyl protons and protons of the hydroxypropyl-CH2 adjacent to the P atom undergo H/D exchange via presumed phosphorus ylide intermediates. Under the same aqueous reaction conditions, tris(3-hydroxypropyl)phosphine, [HO(CH2)3]3P (THPP), does not undergo redox reactions with aliphatic aldehydes but simply promotes a base-catalyzed self-condensation (aldol) reaction. THPP reduction of an aromatic ketone is sluggish, presumably because the carbonyl C-atom is less electrophilic than that present in an aromatic aldehyde.

Journal Article↗

Ruthenium(III) maltolato-nitroimidazole complexes: synthesis and biological activity.

The Ru(III) metronidazole-maltolato and -ethylmaltolato complexes, trans-[RuL(2)(metro)(2)]CF(3)SO(3) (L=ma (1a) or etma (1b)), have been synthesized and tested for potential anti-tumour activity against the human breast cancer cell line MDA-MB-435S using a so-called MTT assay in phosphate-buffered saline; ma=3-hydroxy-2-methylpyran-4-onato, etma=2-ethyl-3-hydroxypyran-4-onato, metro=2-methyl-5-nitro-1H-imidazole-1-ethanol (metronidazole); MTT=3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide. The complexes exhibit lower IC(50) values than our previously reported Ru(III) tris-maltolato and -ethylmaltolato complexes [D.C. Kennedy, A. Wu, B.O. Patrick, B.R. James, Inorg. Chem. 44 (2005) 6529-6535]. An improved synthetic route to the 2-nitroimidazole EF5 (2-(2-nitro-1-H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl)acetamide) is reported, as well as a related synthesis of a 3-nitro-1,2,4-triazole derivative of EF5, triF5 (2-(3-nitro-1-H-triazol-1-yl)-N-(2,2,3,3,3- pentafluoropropyl)acetamide). The complexes [RuL(2)(EF5)(2)]CF(3)SO(3) (4a and 4b) and [Ru(ma)(2)(triF5)(2)]CF(3)SO(3) (5) were prepared from the [RuL(2)(EtOH)(2)]CF(3)SO(3) complexes (3a and 3b); IC(50) values for 3-5 are high. Data on the uptake of Ru by the cells are also reported. The complexes were characterized generally by all or some of the following methods: elemental analyses, NMR, IR and mass spectroscopies, conductivity, and cyclic voltammetry; complexes 1a and 1b were also analyzed by X-ray crystallography.

Antineoplastic Agents↗

New oligophosphines and (hydroxymethyl)phosphonium chlorides.

The new oligophosphines [H2P(CH2)2]2PH, [H2P(CH2)2P(H)CH2]2, and{[(H2P(CH2)2]2PCH2}2 have been made by hydrophosphination of diethyl vinylphosphonate (2) with H2P(CH2)2PH2 (1), using different ratios of 2/1, followed by LiAlH4 reduction of the phosphonate intermediates; the three phosphonate precursors were obtained as oils of varying purity (approximately 90-95%) in low (approximately 20%) to almost quantitative yield. The tri-, tetra-, and hexaphosphines were then treated with formaldehyde in the presence of hydrochloric acid to generate the corresponding water-soluble (hydroxymethyl)phosphonium chlorides {(HOCH2)3P[(CH2)2P(CH2OH)2]n(CH2)2P(CH2OH)3}Cl m (n = 1, m = 3; n = 2, m = 4) and {[(HOCH2)3P(CH2)2]2P(CH2OH)CH2}2Cl6 that were characterized by NMR spectroscopy and elemental analysis. The known (hydroxymethyl)bisphosphonium chloride [(HOCH2)3P(CH2)2]2Cl2 was similarly prepared from H2P(CH2)2PH2, and the determined crystal structure revealed strong hydrogen bonding between the chloride anions and the hydrogen atoms of the hydroxymethyl groups.

Journal Article↗

Tris(pyronato)- and tris(pyridonato)-ruthenium(III) complexes and solution NMR studies.

The water-soluble Ru(III) maltolato, ethylmaltolato, and pyridonato complexes, Ru(O-O')3 (O-O' = ma (1a), etma (1b), pyd (2a)), were synthesized (Hma = 3-hydroxy-2-methyl-4-pyrone, Hetma = 2-ethyl-3-hydroxy-4-pyrone, Hpyd = 3-hydroxy-1,2-dimethyl-4-pyridone). The complexes were characterized by elemental analysis, NMR and IR spectroscopies, MS, solution conductivity, and cyclic voltammetry, and in the case of Ru(ma)(3), by X-ray crystallography, which revealed a mer configuration. The paramagnetic 1H NMR resonances of 1a, 1b, and 2a were assigned using 2D methods (1H COSY and 1H-13C HMQC) and variable-temperature 1H NMR data and showed that 1a and 1b exist in aqueous solution predominantly as a mer isomer, while 2a is a mixture of mer and fac isomers. Although a 13C NMR spectrum could not be measured directly for 1a, a partial (13)C spectrum was generated from the 1H-13C HMQC spectrum. Complexes 1a and 1b were tested for anti-proliferatory activity against the human breast cancer cell line MDA-MB-435S and gave IC50 values of 140 and 90 microM, respectively.

Journal Article↗

Platinum(II) and palladium(II) complexes of bisphosphine ligands bearing o-N,N-dimethylanilinyl substituents: a hint of catalytic olefin hydration.

Platinum(II) and palladium(II) complexes of the potentially hexadentate P,N-donor ligand family Ar2P-X-PAr2 (X = (CH2)2 [dmape], cyclic-C5H8 [dmapcp]; Ar = o-N,N-dimethylanilinyl) are described. In CH2Cl2, the dmape complexes exist as equilibrium mixtures of MCl2(P,P'-dmape) and [MCl(P,P',N-dmape)]Cl isomers (M = Pd, Pt), governed by deltaH(o) = -19 +/- 4 kJ mol(-1) and deltaS(o) = -100 +/- 30 J mol(-1) K(-1) for M = Pt, and deltaH(o) = -11 +/- 7 kJ mol(-1) and deltaS(o) = -60 +/- 20 J mol(-1) K(-1) for M = Pd. The water-soluble dmapcp complexes exist solely in the [MCl(P,P',N-dmapcp)]Cl form, but the free and coordinated anilinyl rings in these complexes are in slow diastereoselective exchange. X-ray crystal structures for MCl2(P,P'-dmape) (M = Pd, Pt), and the [PdCl(P,P',N-dmape)]+ and [PtCl(P,P',N-dmapcp)]+ cations, are presented. Some of the complexes show marginal activity in water for the catalyzed hydration of maleic to malic acid, giving about 6-7% conversion in 24 h at 100 degrees C and substrate:catalyst loadings of 100:1. Attempts to synthesize a PdCl(P,P',N-dmapm)+ species led instead to isolation of [Pd(mu-Cl)(P,P'-dmapm)]2[PF6]2 (dmapm = Ar2PCH2Ar2).

Journal Article↗

Interactions of Rh(III)-dihydrido-bis(phosphine) complexes with semicarbazones.

Interaction of cis,trans,cis-[Rh(H)2(PR3)2(acetone)2]PF6 complexes (R = aryl or R3 = Ph2Me, Ph2Et) under H2 with E-semicarbazones gives the Rh(III)-dihydrido-bis(phosphine)-semicarbazone species cis,trans-[Rh(H)2(PR3)2{R'(R' ')C=N-N(H)CONH2}]PF6, where R' and R' ' are Ph, Et, or Me. The complexes are generally characterized by elemental analysis, 31P{1H} NMR, 1H NMR, and IR spectroscopies, and MS. X-ray analysis of three PPh3 complexes reveals chelation of E-semicarbazones by the imine-N atom and the carbonyl-O atom. In contrast, the corresponding reaction of [Rh(H)2(PPhMe2)2(acetone)2]PF6 with acetophenone semicarbazone gives the ortho-metalated-semicarbazone species cis-[RhH(PPhMe2)2{o-C6H4(Me)C=N-N(H)CONH2}]PF6. The X-ray structure of E-propiophenone semicarbazone is also reported. Rhodium-catalyzed, homogeneous hydrogenation of semicarbazones was not observed even at 40 atm H2.

Journal Article↗

Rhodium-hydrido-benzylamine-triphenylphosphine complexes: solid-state and solution structures and implications in catalyzed imine hydrogenation.

The complexes cis,trans,cis-[Rh(H)(2)(PPh(3))(2)(NH(2)CH(2)Ph)(2)]PF(6) (1) and cis-[Rh(PPh(3))(2)(NH(2)CH(2)Ph)(2)]PF(6) (2) are characterized by X-ray crystallography; the structures are maintained in CH(2)Cl(2) where the species are in equilibrium under H(2). In MeOH and in acetone, loss of amine and/or H(2) can occur. Traces of 1 and 2 are present after a Rh-catalyzed H(2)-hydrogenation of PhCH=NCH(2)Ph in MeOH, where the amine is generated by hydrolysis of the imine substrate through adventitious water. The findings are relevant to catalyst poisoning in the catalytic process.

Journal Article↗

Iodide effects in transition metal catalyzed reactions.

The unique properties of I(-) allow it to be involved in several different ways in reactions catalyzed by the late transition metals: in the oxidative addition, the migration, and the coupling/reductive elimination steps, as well as in substrate activation. Most steps are accelerated by I(-)(for example through an increased nucleophilicity of the metal center), but some are retarded, because a coordination site is blocked. The "soft" iodide ligand binds more strongly to soft metals (low oxidation state, electron rich, and polarizable) such as the later and heavier transition metals, than do the other halides, or N- and O-centered ligands. Hence in a catalytic cycle that includes the metal in a formally low oxidation state there will be less tendency for the metal to precipitate (and be removed from the cycle) in the presence of I(-) than most other ligands. Iodide is a good nucleophile and is also easily and reversibly oxidized to I(2). In addition, I(-) can play key roles in purely organic reactions that occur as part of a catalytic cycle. Thus to understand the function of iodide requires careful analysis, since two or sometimes more effects occur in different steps of one single cycle. Each of these topics is illustrated with examples of the influence of iodide from homogeneous catalytic reactions in the literature: methanol carbonylation to acetic acid and related reactions; CO hydrogenation; imine hydrogenation; and C-C and C-N coupling reactions. General features are summarised in the Conclusions.

Journal Article↗

Imine hydrolysis and role of a rhodium(I)-imine-amine complex in homogeneous H2-hydrogenation of the imine and a rare example of inequivalent NH2 protons.

A Rh-catalyzed, homogeneous hydrogenation of the imine, PhCH(2)N=CHPh, is shown to involve a Rh-imine-amine species that subsequently activates H(2), the amine (benzylamine) being formed via a Rh-catalyzed hydrolysis of the imine by adventitious water. The imine-amine complex, cis-(Rh[P(p-tolyl)(3)](2)(PhCH(2)N=CHPh)(NH(2)CH(2)Ph))PF(6) (2b), is structurally characterized, and the solution (1)H NMR data reveal inequivalent NH(2) protons.

Journal Article↗

Metal-metal bonded homo- and heterobimetallic compounds of Pt(I) and Pd(I) supported by a bridging-N,P:N',P' moiety of a potentially hexadentate ligand.

Reactions of metal-metal bonded homobimetallic (Pd(2)) and heterobimetallic (PtPd) complexes, supported by a P,P'-bridging-bis(P,N-chelating) coordination mode of the potentially hexadentate ligand 1,1-bis[di(o-N,N-dimethylanilinyl)phosphino]methane (dmapm), with CO, diethylacetylenedicarboxylate (DEAD), and thiols (RSH) in CH(2)Cl(2) are described. At room temperature, rac-Pd(2)Cl(2)(mu-N,P:P',N'-dmapm) gives the stable complexes Pd(2)Cl(2)(mu-CO)(2)(mu-P:P'-dmapm) and PdCl(eta2-DEAD)(mu-P:P',N-dmapm)PdCl (which is fluxional in solution), while rac-PtPdCl(2)(mu-N,P:P',N'-dmapm) disproportionates to PtCl(2)(P,P'-dmapm) and Pd metal, although at low temperature intermediate carbonyl species are detected in the CO reaction. The reactions with thiols in the presence of triflic acid (HOTf) generate rac-[MPdCl(2)(mu-SR)(mu-N,P:P',N'-dmapm)][OTf] and H(2) for both M = Pt and Pd. In CH(2)Cl(2), PdX(2)(dmapm) species (X = halide or CN) exist as equilibrium mixtures of P,P'- and P,N-ligated forms. For X = Cl, the P,P'-P,N equilibrium is governed by DeltaH degrees = -5.5 +/- 0.5 kJ mol(-1) and DeltaS degrees = 10 +/- 1 J mol(-1) K(-1), and the ring-strain energy within the P,P'-isomer is approximately 32 kJ mol(-1); the equilibrium increasingly favors the P,N-form with X = CN >> I > Br > Cl. The solid-state structures of rac-[PtPdCl(2)(mu-SEt)(mu-N,P:P',N'-dmapm)][OTf] and PdCl(2)(P,N-dmapm) are presented; the latter contains both bound and free N- and P-atoms of identical types in the same molecule and permits an assessment of sigma- and pi-bonding between these atoms and Pd.

Journal Article↗

Ruthenium(II) sulfoxide-maltolato and -nitroimidazole complexes: synthesis and MTT assay.

Ru(II) sulfoxide-maltolato complexes, Ru(ma)(2)(L)(2) (L = DMSO (1a) and TMSO (1b) or L(2) = BESE (1c)), were synthesized, as well as the analogous ethylmaltolato derivatives, Ru(etma)(2)(L)(2) (2a-c) (ma = 3-hydroxy-2-methylpyran-4-onate, etma = 2-ethyl-3-hydroxypyran-4-onate, TMSO = tetramethylene sulfoxide, BESE = 1,2-bis(ethylsulfinyl)ethane). A Ru(II) bidentate sulfoxide-metronidazole complex, RuCl(2)(BESE)(metro)(2) (3), was also synthesized (metro = metronidazole = 2-methyl-5-nitroimidazole-1-ethanol). The complexes were characterized generally by (1)H NMR, UV-vis, and IR spectroscopies, as well as MS, elemental analysis, solution conductivity, and cyclic voltammetry. The molecular structures of Ru(ma)(2)(S,R-BESE) (1c) and trans-RuCl(2)(R,R-BESE)(metro)(2) (3) were determined by X-ray crystallography. All sulfoxide ligands are S-bonded. The complexes were tested against human breast cancer cells (MDA-MB-435S) using an in vitro MTT assay, a colorimetric determination of cell viability: 2a,b exhibit the lowest IC(50) values of 190 +/- 10 and 220 +/- 10 microM, respectively. Cisplatin exhibits an IC(50) value of 30 +/- 5 microM.

Antineoplastic Agents↗

Solution behavior and structural diversity of bis(dialkylphosphino)methane complexes of palladium.

The preparation of dipalladium complexes containing sterically nondemanding diphosphine (P-P) ligands of the type R(2)PCH(2)PR(2) where R = Me (dmpm) or Et (depm) is reported. Variable-temperature (1)H NMR spectra of the Pd(I)(2) complexes Pd(2)X(2)(dmpm)(2) (X = Cl, Br, or I; the P-P ligands in the Pd(2) complexes are always bridged, but for convenience, the micro -symbol is omitted) show the complexes to be fluxional in solution, the barriers to a ring-flipping process being DeltaG( double dagger ) = 37.9, 39.0, and 43.2 +/- 0.9 kJ mol(-)(1) for the chloro, bromo, and iodo complexes, respectively. Treatment of Pd(2)X(2)(P-P)(2) (X = Cl or Br) with X(2) generates the stable, face-to-face Pd(II)(2) derivatives trans-Pd(2)X(4)(P-P)(2), while oxidation of Pd(2)I(2)(P-P)(2) complexes with I(2) generates a new type of symmetrically di-iodo-bridged, five-coordinate complexes Pd(2)I(2)(micro -I)(2)(dmpm)(2) and Pd(2)I(2)(micro -I)(2)(depm)(2). The molecular crystal structures of four dipalladium(II) complexes are described: trans-Pd(2)Cl(4)(dmpm)(2).2CHCl(3), trans-Pd(2)Br(4)(dmpm)(2), trans-Pd(2)Cl(4)(depm)(2), and Pd(2)I(2)(micro -I)(2)(dmpm)(2). Solution NMR and UV-vis absorption spectra are consistent with the solid-state structures determined by X-ray diffraction. The stability of the dimeric Pd(II) complexes is attributed primarily to ligand steric factors.

Journal Article↗

Diastereoselective formation of a dipalladium(I) complex supported by a bridging tetradentate ligand, and oxidative addition of RS-H across a phosphine-bridged Pd(I)-Pd(I) bond.

The ligand CH2(P(o-C6H4NMe2)2)2 (dmapm) gives access to the first example of a dipalladium(I) complex supported by a tetradentate ligand, Pd2Cl2(mu-N,P,P,N-dmapm), which, unlike the well-known Pd2X2(mu-dppm)2 complexes (X = halide, dppm = bis(diphenylphosphino)methane), reacts with thiols to give addition of RS-H across a phosphine-bridged Pd-Pd bond.

Journal Article↗